AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
2
Israeli startup raises $6.2 million to turn social media video into intelligence
3
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
4
Cyera employees to sell tens of millions in shares at $9 billion valuation
5
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
More news

Larry Ellison

5 stories about Larry Ellison
צפרא כץ מנכ"לית אורקל 2025

Oracle nears $1 trillion valuation as CEO Catz’s prediction comes alive

11.09.25|Sophie Shulman
Less than a year after forecasting a trillion-dollar market cap, Oracle’s cloud and AI deals send its stock soaring.
לארי אליסון אורקל 2024

Larry Ellison leads $23M Series B in Imagene AI to build ‘OpenAI for precision medicine’

01.07.25|Meir Orbach
Israeli startup’s AI platform analyzes biopsies and patient data to match treatments faster.
מנכ"לית אורקל צפרא כץ

Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"

14.11.24|Sophie Shulman
Oracle is doubling down on cloud infrastructure and AI to propel its growth, with an eye on becoming a trillion-dollar company. CEO Safra Catz reveals in an interview how the company’s aggressive investments and strategic expansions are poised to accelerate its financial ascent and why she’s convinced Israel will be flooded with investments after the war.
מייסד אורקל לארי אליסון

Larry Ellison-backed Israeli startup Imagene and Oracle unveil AI model for cancer detection

10.09.24|Sophie Shulman
The startup has launched the CanvOI model, powered by Oracle Cloud, to advance cancer treatment. 
מייסדי Imagene AI. מימין: יהונתן צלח, דין ביתן, שחר פורת והמדענית הראשית ד"ר נורית פז

Larry Ellison leads $21.5 million Series A in cancer treatment startup Imagene AI

02.05.22|Meir Orbach
Using only a digitized biopsy image, the Israeli startup’s diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes